Medical laboratory photo by Louis Reed. (Source: Unsplash)
Stocks of diagnostic chains trade close to their 52-week lows as earnings woes continue in the third quarter ended December.Most pathology and radiology service providers have missed estimates so far. And analysts are flagging concerns about the limited growth visibility and high valuations.Most of these stocks are trading at high multiples despite a sharp correction in their stock prices post-Covid, Rahul Jeewani, a pharma analyst a...